4-((2,2,10,10-Tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)butanoic acid, 97%, 250mg

3-(1-((3,3-Diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride, 99+%, 10mg

1-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

3-Ethoxy-4-[(4-fluorobenzyl)oxy]benzaldehyde, 95.0%, 1g

2-(2,2,2-TRIFLUOROETHYL)BENZOIC ACID, 95%, 1g

Methyl 4-(bromoethynyl)benzoate, 95.0%, 5g

2-(2-methylphenyl)ethanimidamide hydrochloride, 95.0%, 10g

Símbolo de advertencia según ISO 7010 Etiqueta individual, Campo magnético, Longitud lateral 200 mm, 1 pieza

(6-Bromo-3H-imidazo[4,5-b]pyridin-2-yl)methanol, 97.0%, 1g

6-bromo-N-(pyridin-2-ylmethyl)benzo[d]thiazol-2-amine, 95.0%, 250mg

3-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-propionic acid, 95.0%, 250mg

8-Nitro-4-phenyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline, 98%, 50mg

Diethylene Glycol Monovinyl Ether (stabilized with KOH)>96.0%(GC)100mL